229 related articles for article (PubMed ID: 11694237)
21. Oxidized cholesterol in oxidized low density lipoprotein may be responsible for the inhibition of LPS-induced nitric oxide production in macrophages.
Liu SX; Chen Y; Zhou M; Wan J
Atherosclerosis; 1998 Jan; 136(1):43-9. PubMed ID: 9544730
[TBL] [Abstract][Full Text] [Related]
22. Effects of resveratrol on oxidative modification of human low density lipoprotein.
Zou J; Huang Y; Chen Q; Wei E; Cao K; Wu JM
Chin Med J (Engl); 2000 Feb; 113(2):99-102. PubMed ID: 11775553
[TBL] [Abstract][Full Text] [Related]
23. Differences in the metabolism of oxidatively modified low density lipoprotein and acetylated low density lipoprotein by human endothelial cells: inhibition of cholesterol esterification by oxidatively modified low density lipoprotein.
Jialal I; Chait A
J Lipid Res; 1989 Oct; 30(10):1561-8. PubMed ID: 2614259
[TBL] [Abstract][Full Text] [Related]
24. Anti-atherosclerotic potential of gossypetin via inhibiting LDL oxidation and foam cell formation.
Chen JH; Tsai CW; Wang CP; Lin HH
Toxicol Appl Pharmacol; 2013 Oct; 272(2):313-24. PubMed ID: 23845592
[TBL] [Abstract][Full Text] [Related]
25. Oxidation of LDL enhances the cholesteryl ester transfer protein (CETP)-mediated cholesteryl ester transfer rate to HDL, bringing on a diminished net transfer of cholesteryl ester from HDL to oxidized LDL.
Castilho LN; Oliveira HC; Cazita PM; de Oliveira AC; Sesso A; Quintão EC
Clin Chim Acta; 2001 Feb; 304(1-2):99-106. PubMed ID: 11165204
[TBL] [Abstract][Full Text] [Related]
26. Dehydroepiandrosterone markedly inhibits the accumulation of cholesteryl ester in mouse macrophage J774-1 cells.
Taniguchi S; Yanase T; Kobayashi K; Takayanagi R; Nawata H
Atherosclerosis; 1996 Sep; 126(1):143-54. PubMed ID: 8879442
[TBL] [Abstract][Full Text] [Related]
27. Effects of supplementing with vitamin E on the uptake of low density lipoprotein and the stimulation of cholesteryl ester formation in macrophages.
Suzukawa M; Abbey M; Clifton P; Nestel PJ
Atherosclerosis; 1994 Sep; 110(1):77-86. PubMed ID: 7857373
[TBL] [Abstract][Full Text] [Related]
28. Covalent binding of oxidized cholesteryl esters to protein: implications for oxidative modification of low density lipoprotein and atherosclerosis.
Kawai Y; Saito A; Shibata N; Kobayashi M; Yamada S; Osawa T; Uchida K
J Biol Chem; 2003 Jun; 278(23):21040-9. PubMed ID: 12663661
[TBL] [Abstract][Full Text] [Related]
29. Intraperitoneal injection of platelet secretory products into mice increases macrophage uptake of oxidized low density lipoprotein.
Hussein O; Brook GJ; Aviram M
Isr J Med Sci; 1993 Aug; 29(8):453-9. PubMed ID: 8407271
[TBL] [Abstract][Full Text] [Related]
30. Minimally oxidized LDL inhibits macrophage selective cholesteryl ester uptake and native LDL-induced foam cell formation.
Meyer JM; Ji A; Cai L; van der Westhuyzen DR
J Lipid Res; 2014 Aug; 55(8):1648-56. PubMed ID: 24891335
[TBL] [Abstract][Full Text] [Related]
31. Impact of a combination of a calcium antagonist and a beta-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophages and murine J774 cells.
Lesnik P; Dachet C; Petit L; Moreau M; Griglio S; Brudi P; Chapman MJ
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):979-88. PubMed ID: 9157964
[TBL] [Abstract][Full Text] [Related]
32. Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL.
Whitman SC; Sawyez CG; Miller DB; Wolfe BM; Huff MW
J Lipid Res; 1998 May; 39(5):1008-20. PubMed ID: 9610767
[TBL] [Abstract][Full Text] [Related]
33. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein.
Lynch SM; Campione AL; Moore MK
Biochim Biophys Acta; 2000 May; 1485(1):11-22. PubMed ID: 10802245
[TBL] [Abstract][Full Text] [Related]
34. Macrophage-mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor.
Aviram M; Rosenblat M
J Lipid Res; 1994 Mar; 35(3):385-98. PubMed ID: 8014575
[TBL] [Abstract][Full Text] [Related]
35. Low-density lipoproteins of the postprandial state induce cellular cholesteryl ester accumulation in macrophages.
Lechleitner M; Hoppichler F; Föger B; Patsch JR
Arterioscler Thromb; 1994 Nov; 14(11):1799-807. PubMed ID: 7947606
[TBL] [Abstract][Full Text] [Related]
36. Oxidative and malondialdehyde modification of low-density lipoprotein: a comparative study of binding and degradation by macrophages and endothelial cells.
Zhou M; Chen Y; Liu S; Ding Z; Pang Z; Wan J
Br J Biomed Sci; 1998 Sep; 55(3):192-8. PubMed ID: 10367404
[TBL] [Abstract][Full Text] [Related]
37. Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans.
Boyanovsky BB; van der Westhuyzen DR; Webb NR
J Biol Chem; 2005 Sep; 280(38):32746-52. PubMed ID: 16040605
[TBL] [Abstract][Full Text] [Related]
38. [Effect of pravastatin on cholesteryl esters in foam cells and the relation with caveolin-1].
Qin L; Qin XP; Wang Z; Zhu BY; Liao DF
Sheng Li Xue Bao; 2006 Feb; 58(1):47-52. PubMed ID: 16489403
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of low-density lipoprotein and chylomicron remnants on lipid accumulation in human macrophages.
Batt KV; Avella M; Moore EH; Jackson B; Suckling KE; Botham KM
Exp Biol Med (Maywood); 2004 Jun; 229(6):528-37. PubMed ID: 15169972
[TBL] [Abstract][Full Text] [Related]
40. Oxidative degradation of cholesteryl esters in low-density lipoproteins: analysis by liquid chromatography-light scattering and protection by a new synthetic antioxidant, S20478.
Arborati M; Benchorba D; Lesieur I; Bizot-Espiard JG; Guardiola-Lemaitre B; Chapman MJ; Ninio E
Fundam Clin Pharmacol; 1997; 11(1):68-77. PubMed ID: 9182079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
